CompletedNot Applicable

Biomarkers In Seizure To Predict Recurrence and Severe Outcomes

France, United Kingdom300 participantsStarted 2013-01

Plain-language summary

We study the hypothesis that combination of Proteine S100 beta and Copeptin within normal ranges can rule out seizure recurrences and severe outcome, and allow early discharge from the emergency department

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Seizure within 24 hours of ED attendance * Or Seizure in the ED Exclusion Criteria: * Pregnancy * Prisoner * age \< 18 years old

What they're measuring

Combined hospital admission, seizure recurrence, or death at day 7

Timeframe: 7 days

Trial details

NCT IDNCT01774500

SponsorBistro Study Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-01

View on ClinicalTrials.gov More Seizures trials